<DOC>
	<DOCNO>NCT02441075</DOCNO>
	<brief_summary>This study patient undergo hematopoietic stem cell transplant ( HSCT ) . For HSCT , patient need double lumen central venous line ( CVL ) . One common complication HSCT Graft Versus Host Disease ( GVHD ) .Tacrolimus Cyclosporine along methotrexate use together order prevent GVHD . Normally medication give via white lumen blood drawn via unexposed red lumen check blood level medication . If drug accidentally give via wrong lumen ( line ) could cause blood level falsely high . This error could lead patient peripheral blood draw cause pain . The investigator propose add ethanol lock lumen ( line ) see would help clean line therefore prevent error blood test blood draw . An ethanol lock 70 % alcohol inject CVL lumen stay within CVL CVL cap .</brief_summary>
	<brief_title>70 % Ethanol Decontamination CVL Exposed Calcineurine Inhibitors Version 1.0 , 1/9/2014</brief_title>
	<detailed_description>As cyclosporine tacrolimus oil base medication ethanol ( 70 % alcohol ) dissolve oil , investigator hypothesize alcohol lock instill lumen CVL able dissolve leach oil base CNI adhere inside lumen CVL catheter , thus decontaminate . The safety use ethanol via CVL already proven last many year . A study perform neonate result adverse effect use ethanol lock , prove use safe pediatric population . Ethanol use lock disinfect CVLs infect broad range microorganism pediatrics . It also useful treat catheter occlusion cause Lipid formation . By place 70 % ethanol lock two hour contaminate lumen , show degrade biofilm fat formation allow use CVL use 70 % ethanol lock find reduction mechanical integrity polyetherurethane silicone catheter expose long 10 week . Also , structural integrity complication find literature along evidence systemic toxicity use ethanol lock . A retrospective study PICU patient receive ethanol lock 12-24 hour per lumen repeat lock venous access limit , flush 0.2-1mls ethanol catheter end dwell instead withdraw lock . Sixteen patient receive five daily ethanol lock treatment succession , liver enzymes measure two patient mildly elevate transaminase , level significant baseline level . There also report nurse patient complaint side effect . The study state large volume classify 2.3mls ethanol flush central line , patient report flushing , light-headedness , headache , nausea dyspnea . Only 2mls ethanol administer study , ethanol lock withdrawn prior draw level . Therefore , side effect expect .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<criteria>All patient ' age 3 month 30 year eligible study . All patient undergo allogeneic HSCT receive intravenous cyclosporine tacrolimus CVL eligible . Patients hemodynamically compromise need intensive care ICU . Family/patient willing sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>patient</keyword>
	<keyword>BMT</keyword>
	<keyword>cyclosporine</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>HSCT</keyword>
</DOC>